This week's edition of Science has a special section on clinical trials, and how they're figuratively ill. "The clinical trial itself is facing an epidemic -- of rising costs and blurred objectives," says the opening article.
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.